Candel Therapeutics (CADL) Q1 2025 Earnings

Mar 13Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.74
-0.57
-0.4
-0.23

Details

Expected EPS
-0.227612
Actual EPS
-0.4
Surprise EPS
-0.17
Surprise Percent
-75.74%

Description

⁨Candel Therapeutics⁩ (⁦CADL⁩) has reported earnings of ⁦-0.4⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts